Author:
Del Prete Salvatore,Marasco Daniela,De Gennaro Roberto,Del Prete Antonio
Publisher
Heighten Science Publications Corporation
Reference26 articles.
1. 1. Rogozinski LE, Alverson BK, Biondi EA. Diagnosis and treatment of Mycoplasma pneumoniae in children. Minerva Pediatr. 2017; 69: 156-160. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28178776
2. 2. Li P, Zhang Y, Li X, Zhou W, Li X, et al. Mycoplasma hyopneumoniae Mhp597 is a cytotoxicity, inflammation and immunosuppression associated nuclease. Vet Microbiol. 2019; 235: 53-62. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31282379
3. Critical combination of initial markers for predicting refractory Mycoplasma pneumoniae pneumonia in children: a case control study;Choi;Respiratory Research,2019
4. 4. Hsieh CC, Tang RB, Tsai CH, Chen W. Serum interleukin-6 and tumor necrosis factor-alpha concentrations in children with Mycoplasma pneumonia. J Microbiol Immunol Infect. 2001; 34: 109-112. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11456355
5. 5. Hodtsev AS, Choi Y, Spanopoulou E, Posnett DN. Posnett Mycoplasma Superantigen Is a CDR3-dependent Ligand for the T Cell Antigen Receptor. J Exp Med. 1998; 187: 319-327. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9449712